Evidence map›Paper›PMID 38578742›Full record

Trial reportPloS one2024

Strategies for primary HPV test-based cervical cancer screening programme in resource-limited settings in India: Results from a quasi-experimental pragmatic implementation trial.

Anu Mary Oommen, Rita Isaac, Biswajit Paul, David Weller, Madelon L Finkel, Anitha Thomas, Thomas Samuel Ram, Prashanth H R, Anne George Cherian, Vinotha Thomas and 19 more

Abstract readPragmatic Clinical Trial
In one paragraph

Trial report in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Anu Mary OommenCommunity Health Department, Christian Medical College Vellore, Tamil Nadu, India.
Rita IsaacRUHSA Department, Christian Medical College Vellore, Tamil Nadu, India.ORCID 0000-0003-3213-1219
Biswajit PaulRUHSA Department, Christian Medical College Vellore, Tamil Nadu, India.ORCID 0000-0002-2151-0697
David WellerUniversity of Edinburgh, Edinburgh, United Kingdom.
Madelon L FinkelWeill Cornell Medical College, New York, New York, United States of America.
Anitha ThomasDepartment of Gynaecologic Oncology, Christian Medical College Vellore, Tamil Nadu, India.
Thomas Samuel RamDepartment of Radiation Oncology, Christian Medical College Vellore, Tamil Nadu, India.
Prashanth H RRUHSA Department, Christian Medical College Vellore, Tamil Nadu, India.
Anne George CherianCommunity Health Department, Christian Medical College Vellore, Tamil Nadu, India.
Vinotha ThomasDepartment of Gynaecologic Oncology, Christian Medical College Vellore, Tamil Nadu, India.
Vathsala SadanCollege of Nursing Community Health, Christian Medical College Vellore, Tamil Nadu, India.
Rajeswari SivaCollege of Nursing Community Health, Christian Medical College Vellore, Tamil Nadu, India.
Anuradha RoseCommunity Health Department, Christian Medical College Vellore, Tamil Nadu, India.
Tobey Ann MarcusCommunity Health Department, Christian Medical College Vellore, Tamil Nadu, India.
Shalini JeyapaulCommunity Health Department, Christian Medical College Vellore, Tamil Nadu, India.
Sangeetha Rathnam KRUHSA Department, Christian Medical College Vellore, Tamil Nadu, India.
Tabeetha MaliniCommunity Health Department, Christian Medical College Vellore, Tamil Nadu, India.
Surenthiran NRUHSA Department, Christian Medical College Vellore, Tamil Nadu, India.
Paul JebarajRUHSA Department, Christian Medical College Vellore, Tamil Nadu, India.
Neenu Oliver JohnDepartment of Radiation Oncology, Christian Medical College Vellore, Tamil Nadu, India.
Charles RameshRUHSA Department, Christian Medical College Vellore, Tamil Nadu, India.
Jeffers Jayachandra Raj CRUHSA Department, Christian Medical College Vellore, Tamil Nadu, India.
Rakesh Kumar SRUHSA Department, Christian Medical College Vellore, Tamil Nadu, India.
Balaji B VRUHSA Department, Christian Medical College Vellore, Tamil Nadu, India.
Irene Dorathy PCollege of Nursing Community Health, Christian Medical College Vellore, Tamil Nadu, India.
Valliammal MuraliRUHSA Department, Christian Medical College Vellore, Tamil Nadu, India.
Prema NCollege of Nursing Community Health, Christian Medical College Vellore, Tamil Nadu, India.
Kavitha KCommunity Health Department, Christian Medical College Vellore, Tamil Nadu, India.
Priya Ranjani DCommunity Health Department, Christian Medical College Vellore, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn order for low and middle income countries (LMIC) to transition to Human Papilloma Virus (HPV) test based cervical cancer screening, a greater understanding of how to implement these evidence based interventions (EBI) among vulnerable populations is needed. This paper documents outcomes of an implementation research on HPV screening among women from tribal, rural, urban slum settings in India.

methodsA mixed-method, pragmatic, quasi-experimental trial design was used. HPV screening on self-collected cervical samples was offered to women aged 30-60 years. Implementation strategies were 1) Assessment of contextual factors using both qualitative and quantitative methods like key informant interviews (KII), focus group discussions (FGDs), pre-post population sample surveys, capacity assessment of participating departments 2) enhancing provider capacity through training workshops, access to HPV testing facility, colposcopy, thermal ablation/cryotherapy at the primary health care centers 3) community engagement, counselling for self-sampling and triage process by frontline health care workers (HCWs). Outcomes were assessed using the RE-AIM (Reach, Effectiveness, adoption, implementation, maintenance) framework.

resultsScreening rate in 8 months' of study was 31.0%, 26.7%, 32.9%, prevalence of oncogenic HPV was 12.1%, 3.1%, 5.5%, compliance to triage was 53.6%, 45.5%, 84.6% in tribal, urban slum, rural sites respectively. Pre-cancer among triage compliant HPV positive women was 13.6% in tribal, 4% in rural and 0% among urban slum women. Unique challenges faced in the tribal setting led to programme adaptations like increasing honoraria of community health workers for late-evening work and recalling HPV positive women for colposcopy by nurses, thermal ablation by gynaecologist at the outreach camp site.

conclusionsSelf-collection of samples combined with HCW led community engagement activities, flexible triage processes and strengthening of health system showed an acceptable screening rate and better compliance to triage, highlighting the importance of identifying the barriers and developing strategies suitable for the setting.

trial registrationCTRI/2021/09/036130.

Indexed as

Papillomavirus InfectionsUterine Cervical DysplasiaUterine Cervical NeoplasmsColposcopyEarly Detection of CancerFemaleHumansIndiaMass ScreeningPapillomaviridaePregnancyResource-Limited Settings

Identifiers

PMID38578742
PMCPMC10997089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.